SHC · NASDAQ · STOCK
Sotera Health (SHC) Stock Analysis
$18.90
52W $13.09 – $19.85
74/100
$5.43B
33.2
1.77
Is SHC Bullish or Bearish?
Bullish.
Innellis AI committee rates Sotera Health (SHC) Buy with a composite score of 74/100
, based on 5 analysts with 100% agreement.
Last updated September 05, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +1.25 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -18.75 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+1.00 across 1 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 05, 2026
Overall Committee Score
74/100
Agreement
100%
Analysts
5
Conviction
Unanimous
Sector Rank
Top 0%
of 192 Healthcare peers
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
70
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
90
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+1.00 across 1 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3059.07)
Investment Thesis Evolution
Committee score strengthened from 64.0 to 73.8.
- Conviction changed from contested to unanimous.
- Committee agreement increased sharply from 67% to 100%.
- Bullish support removed: 2 signal(s) disappeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Risk Analyst.
- Analyst(s) abstained: Value Analyst.
Analyst-level changes:
- Growth Analyst: score 72->82 (+10).
- Risk Analyst: stance neutral->bullish; score 50->70 (+20).
- Value Analyst abstained (was neutral at 45).
Comparing 2026-09-04 to 2026-09-05 (1 day apart).
Technical Analysis
RSI (14)
50.7
Neutral
MACD Histogram
-0.092
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$18.91
Resistance
$19.39
Bollinger %B
0.48
Inside Bands
Price vs Moving Averages
EMA 9
$19.06
Below
EMA 21
$18.89
Above
EMA 50
$18.23
Above
EMA 200
$16.70
Above
Fundamental Analysis
Valuation
42
Growth
90
Profitability
61
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio
33.2×
P/B Ratio
8.17×
PEG Ratio
0.06
Dividend Yield
0.00%
52W High
$19.85
52W Low
$13.09
Quality & Growth
ROE
1286.2%
ROA
238.9%
Gross Margin
5471.9%
Operating Margin
3623.9%
Revenue Growth YoY
—
Debt / Equity
3.41
AI Fundamental Assessment
P/E ratio of 33.2 (rich relative to a 15-40x range); Price-to-book of 8.2x; PEG ratio of 0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.9%; Return on assets of 2.4%; Net margin of 13.4%; Gross margin of 54.7%; Current ratio of 2.80 (healthy short-term liquidity); Debt-to-equity of 3.41; Free cash flow per share is positive (0.39); Most recent quarter beat estimates by 7.6%; 5 consecutive earnings beats; EPS growth accelerating (-30.8% -> +44.4% QoQ); Average YoY EPS growth of 30.0%; Analyst estimates flat over recent quarters
Get the Full SHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →